Worldwide Cancer Diagnostics Market Analysis & Outlook, 2019 to 2026 - A $249.6 Billion Opportunity - ResearchAndMarkets.com

The "Cancer
Diagnostics Market Analysis Report By Type (Laboratory Tests, Genetic
Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver,
Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2019 -
2026" report has been added to ResearchAndMarkets.com's
offering.

The global cancer diagnostics market size is expected to reach USD 249.6
billion by 2026, exhibiting a 7% CAGR during the forecast period.

Continual introduction of innovative products, coupled with increasing
need for early diagnosis of various diseases, is a prime factor driving
the market. In addition, rapid growth of the healthcare and diagnostics
sector can be attributed to penetration of technologically advanced
laboratory systems that have improved oncological screening in yielding
accurate outcomes. Rising incidence of cancer is triggering demand for
these screening tests and imaging modalities used for monitoring disease
progression.

Collaborative and independent initiatives led by governments and
companies are striving to raise cognizance about the benefits of early
cancer diagnosis. In addition, cancer research organizations, along with
public and private entities, are investing heavily on research projects
to launch advanced diagnostic tools in the market, which are capable of
diagnosing the disease much before the symptoms appear.

Furthermore, giant players are collaborating with governments and other
agencies to enhance patient accessibility to these tests and products.
For instance, Illumina, Inc. launched a new venture called GRAIL with
investors, Jeff Bezos and Bill Gates, with an investment of more than
USD 100 million. GRAIL is mainly focused on blood-based oncological
screening for timely diagnosis of the most common tumor types through
simple laboratory tests.

Further key findings from the report suggest:

• Rapid adoption of technology and escalating need for early diagnosis
  is augmenting the growth of imaging systems. Thus, the segment is
  expected to exhibit the fastest CAGR at 8% during the forecast period
• The breast cancer segment accounted for the largest share based on
  application due to high incidence rate of breast cancer triggering the
  need for its early diagnosis
• In 2018, North America dominated the global space with the largest
  revenue share of 42.0%. Focused research efforts in oncology for
  development of early tumor detection tools, coupled with grants from
  government healthcare agencies, are contributing to a strong medical
  ecosystem to fight cancer in this region
• Asia Pacific is expected to emerge as the fastest growing region
  during the forecast period. Favorable regulatory framework and growing
  patient pool in India, China, and Japan due to support in diagnostic
  process at comparatively lower prices are some of the factors boosting
  the market growth in this region
• Major players competing in this market include GE Healthcare, Abbott,
  Hoffmann-La Roche Ltd., and Siemens Healthcare GmbH. Other prominent
  players include but are not limited to Becton Dickinson & Company,
  Illumina, Inc., Koninklijke Philips N.V., and Hologic, Inc.

Topics Covered

Chapter 1 Methodology and Scope

1.1 Market Segmentation & Scope

1.2 Market Definition

1.3 Information Procurement

1.4 Information Analysis

1.5 Market Formulation & Data Visualization

1.6 Data Validation & Publishing

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.2 Penetration & Growth Prospect Mapping

3.3 Industry Value Chain Analysis

3.4 Technology Overview

3.5 Regulatory Framework

3.6 Market Dynamics

3.7 Cancer Diagnostics Market Analysis Tools

Chapter 4 Cancer Diagnostics Market: Competitive Analysis

4.1 Recent Developments & Impact Analysis, By Key Market Participants

4.2 Vendor Landscape

4.3 Public Companies

4.4 Private Companies

Chapter 5 Cancer Diagnostics Market: Type Estimates and Trend Analysis

5.1 Definition and Scope

5.2 Type Market Share Analysis, 2018 & 2026

5.3 Segment Dashboard

5.4 Global Cancer Diagnostics Market, by Type, 2014 - 2026 (USD Million)

5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026, by Type

Chapter 6 Cancer Diagnostics Market: Application Estimates And Trend
Analysis

6.1 Definition And Scope

6.2 Application Market Share Analysis, 2018 & 2026

6.3 Segment Dashboard

6.4 Global Cancer Diagnostics Market, By Application, 2014-2026 (USD
Million)

6.5 Market Size & Forecasts And Trend Analyses, 2014 To 2026, By
Application

Chapter 7 Cancer Diagnostics Market Regional Estimates & Trend Analysis,
by Product & Application

7.1 Regional Market Snapshot

7.2 Regional Market Share and Leading Players, 2018

7.3 Market Share Analysis by Country/ State

7.4 SWOT Analysis, by Factor (Political & Legal, Economic and
Technological)

7.5 Market Size, & Forecasts and Trend Analysis, 2014 TO 2026

7.6 North America

7.7 Europe

7.8 Asia Pacific

7.9 Latin America

7.10 Middle East and Africa

Chapter 8 Company Profiles

8.1 Abbott Laboratories

8.2 Qiagen N.V.

8.3 F. Hoffmann-La Roche Ltd.

8.4 Siemens Healthineers

8.5 Thermo Fisher Scientific, Inc.

8.6 GE Healthcare

8.7 Hologic, Inc.

8.8 Becton Dickinson & Company

8.9 Koninklijke Philips N.V. (Philips)

8.10 Illumina, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/83mhpv/worldwide_cancer?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190225005816/en/